Cargando…

Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy

Aims. Prostaglandin E2 is the most commonly used drug for cervical ripening prior to labour induction. However, there are concerns regarding uterine tachysystole and nonreassuring fetal heart (N-RFH). Isosorbide mononitrate (IMN) has been used successfully for cervical ripening. The present study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Kavita, Batra, Achla, Batra, Aruna, Aggarwal, Abha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334047/
https://www.ncbi.nlm.nih.gov/pubmed/25763391
http://dx.doi.org/10.1155/2014/147274
_version_ 1782358133858893824
author Agarwal, Kavita
Batra, Achla
Batra, Aruna
Aggarwal, Abha
author_facet Agarwal, Kavita
Batra, Achla
Batra, Aruna
Aggarwal, Abha
author_sort Agarwal, Kavita
collection PubMed
description Aims. Prostaglandin E2 is the most commonly used drug for cervical ripening prior to labour induction. However, there are concerns regarding uterine tachysystole and nonreassuring fetal heart (N-RFH). Isosorbide mononitrate (IMN) has been used successfully for cervical ripening. The present study was conducted to compare the two drugs for cervical ripening at term in hospital. Methods. Two hundred women with term pregnancies referred for induction of labour with Bishop score less than 6 were randomly allocated to receive either 40 mg IMN tablet vaginally (n = 100) or 0.5 mg PGE2 gel intracervically (n = 100). Adverse effects, progress, and outcomes of labour were assessed. Results. PGE2 group had significantly higher postripening mean Bishop score, shorter time from start of medication to vaginal delivery (13.37 ± 10.67 hours versus 30.78 ± 17.29 hours), and shorter labour-delivery interval compared to IMN group (4.53 ± 3.97 hours versus 7.34 ± 5.51 hours). However, PGE2 group also had significantly higher incidence of uterine tachysystole (15%) and N-RFH (11%) compared to none in IMN group, as well as higher caesarean section rate (27% versus 17%). Conclusions. Cervical ripening with IMN was less effective than PGE2 but resulted in fewer adverse effects and was safer especially in high risk pregnancies.
format Online
Article
Text
id pubmed-4334047
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43340472015-03-11 Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy Agarwal, Kavita Batra, Achla Batra, Aruna Aggarwal, Abha Int J Reprod Med Clinical Study Aims. Prostaglandin E2 is the most commonly used drug for cervical ripening prior to labour induction. However, there are concerns regarding uterine tachysystole and nonreassuring fetal heart (N-RFH). Isosorbide mononitrate (IMN) has been used successfully for cervical ripening. The present study was conducted to compare the two drugs for cervical ripening at term in hospital. Methods. Two hundred women with term pregnancies referred for induction of labour with Bishop score less than 6 were randomly allocated to receive either 40 mg IMN tablet vaginally (n = 100) or 0.5 mg PGE2 gel intracervically (n = 100). Adverse effects, progress, and outcomes of labour were assessed. Results. PGE2 group had significantly higher postripening mean Bishop score, shorter time from start of medication to vaginal delivery (13.37 ± 10.67 hours versus 30.78 ± 17.29 hours), and shorter labour-delivery interval compared to IMN group (4.53 ± 3.97 hours versus 7.34 ± 5.51 hours). However, PGE2 group also had significantly higher incidence of uterine tachysystole (15%) and N-RFH (11%) compared to none in IMN group, as well as higher caesarean section rate (27% versus 17%). Conclusions. Cervical ripening with IMN was less effective than PGE2 but resulted in fewer adverse effects and was safer especially in high risk pregnancies. Hindawi Publishing Corporation 2014 2014-07-01 /pmc/articles/PMC4334047/ /pubmed/25763391 http://dx.doi.org/10.1155/2014/147274 Text en Copyright © 2014 Kavita Agarwal et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Agarwal, Kavita
Batra, Achla
Batra, Aruna
Aggarwal, Abha
Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title_full Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title_fullStr Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title_full_unstemmed Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title_short Randomized Comparison of Isosorbide Mononitrate and PGE2 Gel for Cervical Ripening at Term including High Risk Pregnancy
title_sort randomized comparison of isosorbide mononitrate and pge2 gel for cervical ripening at term including high risk pregnancy
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334047/
https://www.ncbi.nlm.nih.gov/pubmed/25763391
http://dx.doi.org/10.1155/2014/147274
work_keys_str_mv AT agarwalkavita randomizedcomparisonofisosorbidemononitrateandpge2gelforcervicalripeningattermincludinghighriskpregnancy
AT batraachla randomizedcomparisonofisosorbidemononitrateandpge2gelforcervicalripeningattermincludinghighriskpregnancy
AT batraaruna randomizedcomparisonofisosorbidemononitrateandpge2gelforcervicalripeningattermincludinghighriskpregnancy
AT aggarwalabha randomizedcomparisonofisosorbidemononitrateandpge2gelforcervicalripeningattermincludinghighriskpregnancy